In vitro activities of new oral beta-lactams and macrolides against Campylobacter pylori.

The in vitro activities of amoxicillin, cefuroxime, ceftetrame, cefetamet, cefixime, tigemonam, erythromycin, roxithromycin, and dirithromycin against 30 clinical isolates of Campylobacter pylori were determined by an agar dilution technique. Roxithromycin and amoxicillin (MICs for 90% of isolates t...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	García-Rodríguez, J A, García Sánchez, J E, García García, M I, García Sánchez, E, Muñoz Bellido, J L
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1989
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172726/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2817868/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.33.9.1650
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!